News & Articles
Selected Filters:
Free Webinar - Physiological Oxygen – Cell Culture’s Missing Link
Learn about the importance of controlling oxygen levels in your cell culture experiments
Corning Introduces New ADME/Tox Products Developed from Mammalian Cells for More In Vivo-like Testing
Corning® TransportoCells™ ABC Transporter Vesicles and Corning Supersomes™ Ultra Human Aldehyde Oxidase (AO) Enzyme are now commercially available
Brain Cancer Discovery Reveals Clues in Quest for New Therapies
Researchers have pinpointed two key molecules that drive the growth of an aggressive type of adult brain cancer
Gyros Protein Technologies Introduces Next Generation Gyrolab Protein A Kit for Biotherapeutics
Kit increases efficiency of residual protein A ligand detection
MilliporeSigma to Present New Solutions and Innovations at IMMUNOLOGY 2017
Advancing immunology research for a healthier world
TxCell and Inserm Collaborate to Develop New CAR-Tregs in Transplantation and Multiple Sclerosis
Expansion of TxCell’s CAR-Treg platform to develop novel proprietary population of CD8+ regulatory T cells
More Solar Panels for Life Science Manufacturer
Improving Joint Health with Putative Therapeutics at Matis, Iceland’s Food & Biotechnology Research Institute
Use of cell imaging technology enables cutting-edge research into the assessment of bioactive compounds in cell lines
Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius® Bioreactors
Fully scalable system streamlines drug development and production with sizes ranging from 3-liter bench-top to 1000-liter manufacturing scale
UMMS Researchers Receive amfAR Grant to Eliminate HIV Reservoirs Using Gene Editing
UMassMedNow, UMass Medical School’s news service, reports how Jeremy Luban, MD and Scot Wolfe PhD are exploring the novel CRISPR/Cpf1 technique
ZEISS Opens New Microscopy Customer Center
Aeolus Receives BARDA Decision Regarding Additional Options for Lung ARSDevelopment Contract and Files Response to Assertions Made
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
























